Abstract

This study has picked up an essential question for the Indian pharmaceutical industry, whether innovation and internationalisation follow a two-way relationship during the product patent regime. This study analyzes the role of product, process and variety of innovation on exporting activities of 168 pharmaceutical firms from 2006 to 2013. For this purpose, this study applies two-stage least square probit and tobit model on innovation and export equation separately. The results show the feedback relation between export and innovative performance while there is a differential effect of product and process innovation on exporting. The results strongly support the learning-by-exporting and product-life cycle hypothesis. European origin firms are more likely to be innovative and export-oriented, while U.S. origin firms influence the firms' innovative performance. Business strategy should take account of benefits from the dynamic interaction of innovative and exporting activities and make their strategic decisions carefully.

摘要

这项研究为印度制药业提出了一个基本问题，即创新和国际化在产品专利制度中是否遵循双向关系。本研究分析了 2006 年至 2013 年 168 家制药企业的产品、工艺和创新种类对出口活动的作用。为此，本研究分别应用两阶段最小二乘概率和 Tobit 模型对创新和出口方程进行分析。结果表明出口与创新绩效之间存在反馈关系，而产品和工艺创新对出口的影响存在差异。结果强烈支持通过出口学习和产品生命周期假设。欧洲原产企业更有可能具有创新性和出口导向性，而美国原产企业则影响企业的 创新性能。商业战略应考虑创新活动和出口活动的动态互动带来的好处，并谨慎做出战略决策。